Labels Should Tell You How Drug Compares With Similar Treatments Say Researchers

Researchers from a leading US medical institution want the US Food and Drug Administration (FDA) to require drug companies to describe on the label how the new product compares with existing ones and suggest that in many cases they would reveal the new one was no better and this would make patients and insurers less likely to pay for newer treatments.